Cargando…

Long-term cellular immune response in immunocompromised unvaccinated COVID-19 patients undergoing monoclonal antibody treatment

Immunocompromised patients are at increased risk for a severe course of COVID-19. Treatment of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection with anti-SARS-CoV-2 monoclonal antibodies (mAbs) has become widely accepted. However, the effects of mAb treatment on the long-term p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thümmler, Laura, Konik, Margarethe, Lindemann, Monika, Fisenkci, Neslinur, Koldehoff, Michael, Gäckler, Anja, Horn, Peter A., Theodoropoulos, Fotis, Taube, Christian, Zettler, Markus, Anastasiou, Olympia Evdoxia, Braß, Peer, Jansen, Sarah, Witzke, Oliver, Rohn, Hana, Krawczyk, Adalbert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606643/ https://www.ncbi.nlm.nih.gov/pubmed/36311723 http://dx.doi.org/10.3389/fimmu.2022.980698

Ejemplares similares

Early Treatment with Monoclonal Antibodies or Convalescent Plasma Reduces Mortality in Non-Vaccinated COVID-19 High-Risk Patients
por: Thümmler, Laura, et al.
Publicado: (2022)

Cellular and Humoral Immunity after the Third Vaccination against SARS-CoV-2 in Hematopoietic Stem-Cell Transplant Recipients
por: Thümmler, Laura, et al.
Publicado: (2022)

Long-Term SARS-CoV-2 Specific Immunity Is Affected by the Severity of Initial COVID-19 and Patient Age
por: Konik, Margarethe, et al.
Publicado: (2021)

Cellular and Humoral Immunity against Different SARS-CoV-2 Variants Is Detectable but Reduced in Vaccinated Kidney Transplant Patients
por: Thümmler, Laura, et al.
Publicado: (2022)

COVID-19 in Elderly, Immunocompromised or Diabetic Patients—From Immune Monitoring to Clinical Management in the Hospital
por: Wünsch, Korbinian, et al.
Publicado: (2022)

Humoral and Cellular Vaccination Responses against SARS-CoV-2 in Hematopoietic Stem Cell Transplant Recipients
por: Lindemann, Monika, et al.
Publicado: (2021)

GNB3 c.825c>T polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine
por: Čiučiulkaitė, Ieva, et al.
Publicado: (2022)

SARS‐CoV‐2‐specific humoral and cellular immunity in two renal transplants and two hemodialysis patients treated with convalescent plasma
por: Lindemann, Monika, et al.
Publicado: (2021)

Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)

Prospective, Longitudinal Study on Specific Cellular Immune Responses after Vaccination with an Adjuvanted, Recombinant Zoster Vaccine in Kidney Transplant Recipients
por: Lindemann, Monika, et al.
Publicado: (2022)

Evidence of extensive cellular immune response after SARS-CoV-2 vaccination in ocrelizumab-treated patients with multiple sclerosis
por: Pompsch, Mosche, et al.
Publicado: (2021)

Low avidity circulating SARS-CoV-2 reactive CD8+ T cells with proinflammatory TEMRA phenotype are associated with post-acute sequelae of COVID-19
por: Paniskaki, Krystallenia, et al.
Publicado: (2023)

SARS-CoV-2 Seroprevalence in Healthcare Workers in Germany: A Follow-Up Study
por: Korth, Johannes, et al.
Publicado: (2021)

Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5
por: Bormann, Maren, et al.
Publicado: (2023)

Akutes Nierenversagen bei COVID-19
por: Gäckler, A., et al.
Publicado: (2020)

The GNB3 c.825C>T (rs5443) polymorphism and protection against fatal outcome of corona virus disease 2019 (COVID-19)
por: Möhlendick, Birte, et al.
Publicado: (2022)

COVID-19 associated acute transplant failure after AB0-incompatible living donor kidney transplantation – a case report
por: Boss, Kristina, et al.
Publicado: (2023)

Peripheral HLA-G/ILT-2 immune checkpoint axis in acute and convalescent COVID-19 patients
por: Rohn, Hana, et al.
Publicado: (2023)

Seasonality of Non-SARS, Non-MERS Coronaviruses and the Impact of Meteorological Factors
por: Anastasiou, Olympia E., et al.
Publicado: (2021)

Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis
por: Jahn, Michael, et al.
Publicado: (2021)

Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech)
por: Korth, Johannes, et al.
Publicado: (2021)

Wellenreiten – 12 Monate COVID-19 im Maximalversorger
por: Fistera, David, et al.
Publicado: (2021)

Upregulation of miRNA-200c during Disease Progression in COVID-19 Patients
por: van de Sand, Lukas, et al.
Publicado: (2022)

SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients
por: Korth, Johannes, et al.
Publicado: (2020)

Decline of Humoral Responses 6 Months after Vaccination with BNT162b2 (Pfizer–BioNTech) in Patients on Hemodialysis
por: Jahn, Michael, et al.
Publicado: (2022)

Establishment of an ELISpot Assay to Detect Cellular Immunity against S. pneumoniae in Vaccinated Kidney Transplant Recipients
por: Gäckler, Anja, et al.
Publicado: (2021)

The Course of Anti-HBc Antibodies over Time in Immunocompromised Hosts
por: Holtkamp, Caroline, et al.
Publicado: (2022)

False-Positive Screening and Confirmatory HIV Diagnostic Test in a Patient with Cured SARS-CoV-2 Infection Is Not Mediated by Env/Spike Cross-Reactive Antibodies
por: Elsner, Carina, et al.
Publicado: (2023)

Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG
por: Schwarzkopf, Sina, et al.
Publicado: (2021)

Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)

Evaluation of hemostasis in patients with end-stage renal disease
por: Gäckler, Anja, et al.
Publicado: (2019)

Thrombotische Mikroangiopathie: Diagnose und Therapie
por: Gäckler, Anja, et al.
Publicado: (2021)

Fading SARS-CoV-2 humoral VOC cross-reactivity and sustained cellular immunity in convalescent children and adolescents
por: Paniskaki, Krystallenia, et al.
Publicado: (2023)

Evidence of cell-mediated immune response in kidney transplants with a negative mRNA vaccine antibody response
por: Dolff, Sebastian, et al.
Publicado: (2021)

Randomized, open-label, comparative phase IV study on the bioavailability of Ciclosporin Pro (Teva) versus Sandimmun® Optoral (Novartis) under fasting versus fed conditions in patients with stable renal transplants
por: Gäckler, Anja, et al.
Publicado: (2019)

Low efficacy of vaccination against serogroup B meningococci in patients with atypical hemolytic uremic syndrome
por: Mülling, Nils, et al.
Publicado: (2020)

Associations Between Built Environment Factors and SARS-CoV-2 Infections at the Neighbourhood Level in a Metropolitan Area in Germany
por: Schmiege, Dennis, et al.
Publicado: (2023)

Fear of Death during COVID-19 Does Not Explain Post-Infection Depression Symptoms beyond Reported Symptoms during the Infection in COVID-19 Survivors
por: Speichert, Leoni-Johanna, et al.
Publicado: (2022)

Effect of HLA-G5 Immune Checkpoint Molecule on the Expression of ILT-2, CD27, and CD38 in Splenic B cells
por: Rohn, Hana, et al.
Publicado: (2022)

Immunocompromise among vaccinated versus unvaccinated COVID-19 cases admitted to critical care in Ireland, July to October 2021
por: Kelly, David, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rgt3bndtcr1835q7hg4gvqn4qd